%0 Journal Article
%T Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties
%A E. O. Jimmy
%J Journal of Biosciences and Medicines
%P 23-28
%@ 2327-509X
%D 2019
%I Scientific Research Publishing
%R 10.4236/jbm.2019.71003
%X Effects of fansidar in
alloxan-induced diabetes were investigated in thirty (30) male and female albino rats for 28 days. The
results showed a steady weekly decrease in blood glucose concentration in
induced diabetic rats after fansidar treatment. In week 1, <i>i.e.</i> 7 days, there was significant difference in the blood glucose
levels between the control and diabetic rats (P &lt; 0.05) <i>i.e.</i> high glucose concentration, same in week II <i>i.e.</i> 14 days. However, in day 21 <i>i.e.</i> week
III there was a significant reduction in the blood glucose concentration
compared with control P &lt; 0.05. The same results were obtained in week IV <i>i.e.</i> in 28 days treatment. The result
has shown that fansidar has antidiabetic potentials on long term durational
administration.
%K Durational Dosage
%K Diabetes
%K Antidiabetic Potentials
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=89699